Persistent propagation of variant creutzfeldt-jakob disease agent in murine spleen stromal cell culture with features of mesenchymal stem cells

Journal of Virology

Volumn 82, Issue 21, 2008, Pages 10959-10962

  Akimov, Sergey ^a   Yakovleva, Oksana ^a   Vasilyeva, Irina ^a   McKenzie, Carroll ^a   Cervenakova, Larisa ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE AGENT; CRYOPRESERVATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOBLOTTING; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; STROMA CELL; VARIANT CREUTZFELDT JAKOB DISEASE; ANIMAL; CREUTZFELDT JAKOB DISEASE; CYTOLOGY; HUMAN; METABOLISM; PRION; SPLEEN;

CREUTZFELDT-JAKOB DISEASE PRION; MURINAE;

ANIMALS; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; MESENCHYMAL STEM CELLS; MICE; PRIONS; SPLEEN; STROMAL CELLS;

EID: 55249114929     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01085-08     Document Type: Article

References (30)

1. Arima, K., N. Nishida, S. Sakaguchi, K. Shigematsu, R. Atarashi, N. Yamaguchi, D. Yoshikawa, J. Yoon, K. Watanabe, N. Kobayashi, S. Mouillet-Richard, S. Lehmann, and S. Katamine. 2005. Biological and biochemical characteristics of prion strains conserved in persistently infected cell cultures. J. Virol. 79:7104-7112.
2. Arjona, A., L. Simarro, F. Islinger, N. Nishida, and L. Manuelidis. 2004. Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures. Proc. Natl. Acad. Sci. USA 101:8768-8773.
3. Bruce, M. E., I. McConnell, R. G. Will, and J. W. Ironside. 2001. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 358:208-209.
4. Butler, D. A., M. R. Scott, J. M. Bockman, D. R. Borchelt, A. Taraboulos, K. K. Hsiao, D. T. Kingsbury, and S. B. Prusiner. 1988. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J. Virol. 62:1558-1564.
5. Cervenakova, L., O. Yakovleva, C. McKenzie, S. Kolchinsky, L. McShane, W. N. Drohan, and P. Brown. 2003. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 43:1687-1694.
6. Cervenakova, L., O. Yakovleva, and C. McKenzie. 2006. Demonstration of protease-resistant PrP in spontaneously developing lymphoreticular tumors of mice infected with vCJD: implications for vCJD surveillance. Emerg. Infect. Dis. 12:511-513.
7. Clarke, M. C., and D. A. Haig. 1970. Evidence for the multiplication of scrapie agent in cell culture. Nature 225:100-101.
8. Clarke, M. C., and G. C. Millson. 1976. Infection of a cell line of mouse L fibroblasts with scrapie agent. Nature 261:144-145.
9. Courageot, M. P., N. Daude, R. Nonno, S. Paquet, M. A. Di Bari, A. Le Dur, J. Chapuis, A. F. Hill, U. Agrimi, H. Laude, and D. Vilette. 2008. A cell line infectible by prion strains from different species. J. Gen. Virol. 89:341-347.
10. Dlakic, W. M., E. Grigg, and R. A. Bessen. 2007. Prion infection of muscle cells in vitro. J. Virol. 81:4615-4624.
11. Eurosurveillance editorial office. 18 January 2007. Fourth case of transfusion-associated vCJD infection in the United Kingdom. Euro. Surveill. 12:E070118.4. http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId3117.
12. Gustafson, D. P., and C. L. Kanitz. 1965. Evidence of the presence of scrapie in cell cultures of brain, p. 221-236. In D. C. Gaidusek, C. J. Gibbs, Jr., and M. Alpers (ed.), Slow, latent and temperate virus infections, NINDB monograph no. 2. U.S. Department of Health, Education and Welfare, Washington, DC.
13. Hewitt, P. E., C. A. Llewelyn, J. Mackenzie, and R. G. Will. 2006. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang. 91:221-230.
14. Hilton, D. A., A. C. Ghani, L. Conyers, P. Edwards, L. McCardle, D. Ritchie, M. Penney, D. Hegazy, and J. W. Ironside. 2004. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J. Pathol. 203:733-739.
15. Hilton, D. A., J. Sutak, M. E. Smith, M. Penney, L. Conyers, P. Edwards, L. McCardle, D. Ritchie, M. W. Head, C. A. Wiley, and J. W. Ironside. 2004. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J. Clin. Pathol. 57:300-302.
16. Iwamaru, Y., T. Takenouchi, K. Ogihara, M. Hoshino, M. Takata, M. Imamura, Y. Tagawa, H. Hayashi-Kato, Y. Ushiki-Kaku, Y. Shimizu, H. Okada, M. Shinagawa, H. Kitani, and T. Yokoyama. 2007. Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains. J. Virol. 81:1524-1527.
17. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97-104.
18. Nadri, S., M. Soleimani, R. H. Hosseni, M. Massumi, A. Atashi, and R. Izadpanah. 2007. An efficient method for isolation of murine bone marrow mesenchymal stem cells. Int. J. Dev. Biol. 51:723-729.
19. Ni, K., and H. C. O'Neill. 1998. Hemopoiesis in long-term stroma-dependent cultures from lymphoid tissue: production of cells with myeloid/dendritic characteristics. In Vitro Cell. Dev. Biol. Anim. 34:298-307.
20. Pankiewicz, J., F. Prelli, M. S. Sy, R. J. Kascsak, R. B. Kascsak, D. S. Spinner, R. I. Carp, H. C. Meeker, M. Sadowski, and T. Wisniewski. 2006. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. Eur. J. Neurosci. 23:2635-2647.
21. Peister, A., J. A. Mellad, B. L. Larson, B. M. Hall, L. F. Gibson, and D. J. Prockop. 2004. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103:1662-1668.
22. Ponzio, N. M., P. H. Brown, and G. J. Thorbecke. 1986. Host-tumor interactions in the SJL lymphoma model. Int. Rev. Immunol. 1:273-301.
23. Race, R. E., L. H. Fadness, and B. Chesebro. 1987. Characterization of scrapie infection in mouse neuroblastoma cells. J. Gen. Virol. 68:1391-1399.
24. Raymond, G. J., E. A. Olsen, K. S. Lee, L. D. Raymond, P. K. Bryant III, G. S. Baron, W. S. Caughey, D. A. Kocisko, L. E. McHolland, C. Favara, J. P. Langeveld, F. G. van Zijderveld, R. T. Mayer, M. W. Miller, E. S. Williams, and B. Caughey. 2006. Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease. J. Virol. 80:596-604.
25. Tang, J. C., F. C. Ho, A. C. Chan, and G. Srivastava. 1998. Clonality of lymphomas at multiple sites in SJL mice. Lab. Investig. 78:205-212.
26. Tateishi, J., M. Ohta, M. Koga, Y. Sato, and Y. Kuroiwa. 1979. Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann. Neurol. 5:581-584.
27. Vilette, D., O. Andreoletti, F. Archer, M. F. Madelaine, J. L. Vilotte, S. Lehmann, and H. Laude. 2001. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc. Natl. Acad. Sci. USA 98:4055-4059.
28. Vilette, D. 2008. Cell models of prion infection. Vet. Res. 39:10.
29. Vorberg, I., A. Raines, and S. A. Priola. 2004. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro. J. Biol. Chem. 279:29218-29225.
30. Wadsworth, J. D., S. Joiner, J. M. Linehan, M. Desbruslais, K. Fox, S. Cooper, S. Cronier, E. A. Asante, S. Mead, S. Brandner, A. F. Hill, and J. Collinge. 2008. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc. Natl. Acad. Sci. USA 105:3885-3890.